Prostatype Genomics AB
@prostatypegenomics.com
Prostatype Genomics Prostate cancer is one of the most common forms of cancer and approximately 1.3 million men are diagnosed annually. Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test Prostatype®. Prostatype® is a genetic test that provides a comprehensive assessment of the aggressiveness of prostate cancer. The Prostatype […]
Prostatype Genomics AB's Company Logos
Prostatype Genomics AB's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#71AADD
Viking
113, 170, 221
208, 61, 65
49, 23, 0, 13
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#172D4D
Nile Blue
23, 45, 77
216, 54, 20
70, 42, 0, 70
About Prostatype Genomics AB
Prostatype Genomics AB is a leading brand that specializes in providing a unique gene test called Prostatype. This test offers a comprehensive assessment of a patient's prostate cancer aggressiveness, providing valuable information for personalized treatment plans. With approximately 1.
3 million men diagnosed with prostate cancer annually, Prostatype's prognostic gene test is essential for accurately determining the aggressiveness of the cancer. Using prostate tissue obtained from the biopsy at the time of diagnosis, Prostatype analyzes the gene expression of the sample. This information is then combined with other clinical parameters to calculate the P-Score, which indicates the risk of dying from prostate cancer.
This precise analysis not only saves lives but also improves the quality of life for patients and reduces costs for the healthcare system. Prostatype Genomics AB is committed to advancing prostate cancer diagnostics and treatment through their cutting-edge Prostatype® Test System. With a dedicated team of experts and a strong mission, they aim to make a significant impact in the field of prostate cancer research and patient care.
Visit their website for more information and resources
Company type
Public Company
Year founded
2007
Company size
2-10 employees
